CD4 and cancer: The analysis revealed that AC-GV patients, despite having the poorest prognosis, exhibited the highest estimated enrichment score of TME cells, especially CD4+ T cells, M1 macrophages, activated dendritic cells, and cancer-associated fibroblasts (CAFs).